Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
Association of Cardiovascular Disease With Respiratory Disease
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience
The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors